Aurora cannabis files full year results and announces fiscal 2024 fourth quarter

Delivers record annual adjusted ebitda 1   of $12.8 million nasdaq | tsx: acb q4 represents the sixth consecutive quarter of positive adjusted ebitda 1 increased total quarterly net revenue 5% yoy to $67.4 million, global medical cannabis net revenue 1 grew by 20% yoy to $45.6 million ended the fiscal year with a cash position of ~$180 million with cannabis business debt-free2 re-affirms target of reaching positive free cash flow1 by december 31, 2024 edmonton, ab , june 20, 2024 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora") (nasdaq: acb) (tsx: acb), a leading canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2024. as the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for q4 2024 ending march 31, 2024 is q3 2023 ending march 31, 2023.
ACB Ratings Summary
ACB Quant Ranking